Altair Nanotechnologies Reports First Quarter 2012 Financial Results

RENO, NV -- (Marketwire) -- May 10, 2012 -- Altair Nanotechnologies Inc. (Altair) (NASDAQ: ALTI), a provider of advanced lithium-ion battery storage systems, today reported financial results for the first quarter ended March 31, 2012.

Financial Highlights for the first quarter of 2012 compared to the first quarter of 2011

  • Revenues decreased to $0.3 million from $2.6 million.
  • Gross loss remained constant at $(0.2) million.
  • Operating expenses of $4.8 million compared to $5.7 million.
  • Net loss of $4.9 million compared to $5.9 million.
  • Cash used in operating and investing activities of $6.1 million compared to $4.6 million.

Recent Highlights

  • On April 18, 2012, our subsidiary Altair Nanotechnologies (China) Co., Ltd. ("Altair China") entered into an Agreement (the "Agreement") with Wu'an Municipal People's Government ("Wu'an") and Handan Municipal People's Government ("Handan") regarding the establishment by Altair China of a manufacturing facility in the City of Wu'an, in Hebei Province in China. The Agreement contemplates the purchase by Wu'an and Handan of electric buses beginning in late 2012 and continuing over a period of years, and the future purchase of electric taxis and energy storage systems.
  • On April 1, 2012, our Board of Directors appointed Alexander Lee as interim Chief Executive Officer of the Company and appointed Liming Zou (a/k/a Albert Zou) as President of the Company.

For the 2012 first quarter, Altair reported revenues of $0.3 million, down from $2.6 million in the first quarter of 2011. This decrease is primarily due to the sale of $1.7 million of products to a Chinese entity during the first quarter of 2011.

Net loss was $4.9 million, or $0.07 per share, compared to a net loss of $5.9 million, or $0.22 per share, for the first quarter of 2011. The basic and diluted weighted average shares outstanding for the quarter were 69.5 million, compared to 26.8 million for the same period in 2011.

"The establishment of Altair China, the execution of our economic cooperation agreement, and our plan to expand Altair's operations into China shall create new and meaningful opportunities for the Company. It will take time and effort to develop these opportunities, but this is an important and critical step to gain access to customers in Asia," said Alexander Lee, Altair's interim Chief Executive Officer.

For the quarter, gross loss remained constant at $(0.2) million and operating expenses were lower by 16 percent, falling from $5.7 million in the first quarter of 2011 to $4.8 million for the same period this year. The primary driver for the reduced operating expenses was the result of constrained spending in all areas of the company.

Altair's cash and cash equivalents decreased by $6.0 million, from $46.5 million at December 31, 2011 to $40.5 million at March 31, 2012. This is primarily due to the $5.7 million of cash used in operating activities during the quarter ending March 31, 2012. The bulk of the cash used in operations went to cover normal compensation and non-labor expenses, and the build-up of work in process inventory related to the fulfillment of customer sales backlog.

First Quarter 2012 Conference Call
Altair will hold a conference call to discuss its first quarter 2012 results on Thursday, May 10, 2012 at 11:00 a.m. Eastern Daylight Time (EDT). Shareholders and members of the investment community are invited to participate in the conference call. The dial-in number for both U.S. and international callers is +1 678-224-7719. Please dial in to the conference five minutes before the call is scheduled to begin. Ask the operator for the Altair Nanotechnologies call.

Post call, a phone-based audio replay will be available from 2:00 p.m. EDT, Thursday, May 10, 2012 until Midnight EDT, May 17, 2012. It can be accessed by dialing +1 404-537-3406 and entering the conference number 78414687. Additionally, the conference call and replay will be available online, and can be accessed by visiting Altair's web site, www.altairnano.com.

About Altair Nanotechnologies, Inc.
Headquartered in Reno, Nev. with manufacturing in Anderson, Ind., Altair is a leading provider of energy storage systems for clean, efficient power and energy management. Altair's lithium-titanate based battery systems are among the highest performing and most scalable, with applications that include complete energy storage systems for use in providing frequency regulation and renewables integration for the electric grid, and battery modules and systems for transportation and industrial applications. For more information please visit Altair at www.altairnano.com.

Forward-Looking Statements
This report may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause Altair's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this report. These risks include the risk that the government entities with which the Company has contracted will be unable to fulfill their commitment due to legal limitations, including certain procedures required in connection with land use grants and major product purchases; that the government entities will not fulfill their commitments for political or other discretionary reasons, in which case the Company will have no, or limited, remedies; that the Company will run into regulatory, finance or other obstacles as it attempts to expand its operations into China; that the Company interest may be harmed by the absence from the Agreement of terms and conditions that are customary in contracts under U.S. law; that the Company will be unable to expand capacity (or contract with third parties) in order to meet the demand of product orders, particularly products like electric vehicles which the Company does not itself manufacture; that the Company will not experience expected costs savings as a result of its expansion into China and that the Company will not experience an increase in sales volume or, even if it experiences such an increase, that the Company will experience low (or negative) gross margins and not operate profitably in China. Other risks are identified in Altair's most recent Annual Report on Form 10-K filed with the SEC. Such forward-looking statements speak only as of the date of this release. Altair expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in Altair expectations or results or any change in events.

Tables Follow

                                                                            
               ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES                
                        CONSOLIDATED BALANCE SHEETS                         
      (Expressed in thousands of United States Dollars, except shares)      
                                                                            
                                                                            
                                                                               (Unaudited)                                  
                                                                                                  March  31,          December  31,  
                                                                                                        2012                      2011          
                                                                                              -------------    -------------  
                                        ASSETS                                                                                                    
Current  assets                                                                                                                            
    Cash  and  cash  equivalents                                        $            40,460    $            46,519  
    Restricted  cash                                                                                293                            -  
    Accounts  receivable,  net                                                              127                        333  
    Product  inventories,  net                                                          8,926                    7,220  
    Prepaid  expenses  and  other  current  assets                        2,239                    2,240  
                                                                                              -------------    -------------  
        Total  current  assets                                                            52,045                  56,312  
                                                                                                                                                        
Property,  plant  and  equipment,  net                                          6,575                    6,870  
                                                                                                                                                        
Patents,  net                                                                                          331                        350  
                                                                                              -------------    -------------  
                                                                                                                                                        
                Total  Assets                                                      $            58,951    $            63,532  
                                                                                              =============    =============  
                                                                                                                                                        
          LIABILITIES  AND  STOCKHOLDERS'  EQUITY                                                                      
                                                                                                                                                        
Current  Liabilities                                                                                                                  
    Trade  accounts  payable                                              $              5,984    $              5,870  
    Accrued  salaries  and  benefits                                                    875                    1,132  
    Accrued  warranty                                                                              364                        354  
    Accrued  liabilities                                                                        452                        421  
    Deferred  revenues                                                                        2,008                    1,616  
    Warrant  liabilities                                                                        577                        654  
    Current  portion  of  long-term  debt                                                5                          12  
                                                                                              -------------    -------------  
        Total  current  liabilities                                                  10,265                  10,059  
                                                                                                                                                        
                                                                                                                                                        
                Total  Liabilities                                                          10,265                  10,059  
                                                                                              -------------    -------------  
                                                                                                                                                        
                                                                                                                                                        
Stockholders'  equity                                                                                                                
    Common  stock,  no  par  value,  unlimited  shares                                                            
      authorized;  69,452,487  shares  issued  and                                                                  
      outstanding  at  March  31,  2012  and  December                                                              
      31,  2011                                                                                    245,617                245,617  
    Additional  paid  in  capital                                                    12,351                  12,279  
    Accumulated  deficit                                                              (209,282)            (204,423)
                                                                                              -------------    -------------  
        Total  stockholders'  equity                                                48,686                  53,473  
                                                                                                                                                        
            Total  Liabilities  and  Stockholders'                                                                      
              Equity                                                                    $            58,951    $            63,532  
                                                                                              =============    =============  
                                                                                                                                                        
                                                                                                                                                        
                                                                                                                                                        
                              ALTAIR  NANOTECHNOLOGIES  INC.  AND  SUBSIDIARIES                                
                                      CONSOLIDATED  STATEMENTS  OF  OPERATIONS                                        
    (Expressed  in  thousands  of  United  States  Dollars,  except  shares  and  per      
                                                              share  amounts)                                                              
                                                                (Unaudited)                                                                  
                                                                                                                                                        
                                                                                                                                                        
                                                                                                        Three  Months  Ended            
                                                                                                  March  31,            March  31,      
                                                                                              -------------    -------------  
                                                                                                        2012                      2011          
                                                                                              -------------    -------------  
Revenues                                                                                                                                        
    Product  sales                                                                $                  197    $              2,366  
    License  fees                                                                                        60                          60  
    Commercial  collaborations                                                                -                            2  
    Contracts  and  grants                                                                          -                        123  
                                                                                              -------------    -------------  
        Total  revenues                                                                              257                    2,551  
                                                                                              -------------    -------------  
                                                                                                                                                        
Cost  of  goods  sold                                                                                                                    
    Product                                                                                                406                    2,611  
    Contracts  and  grants                                                                          -                        128  
    Warranty  and  inventory  reserves                                                  14                          46  
                                                                                              -------------    -------------  
        Total  cost  of  goods  sold                                                          420                    2,785  
                                                                                              -------------    -------------  
                                                                                                                                                        
Gross  loss                                                                                            (163)                    (234)
                                                                                                                                                        
Operating  expenses                                                                                                                    
    Research  and  development                                                          1,833                    2,056  
    Sales  and  marketing                                                                        920                    1,051  
    General  and  administrative                                                      1,749                    2,171  
    Depreciation  and  amortization                                                    269                        375  
    Loss  on  disposal  of  assets                                                              -                          16  
                                                                                              -------------    -------------  
        Total  operating  expenses                                                      4,771                    5,669  
                                                                                              -------------    -------------  
Loss  from  operations                                                                    (4,934)                (5,903)
                                                                                              -------------    -------------  
                                                                                                                                                        
Other  income  (expense)                                                                                                            
    Interest  expense                                                                                (2)                        (7)
    Realized  loss  on  investment                                                            -                          (1)
    Change  in  fair  value  of  warrant  liabilities                          77                            -  
                                                                                              -------------    -------------  
        Total  other  income  (expense),  net                                          75                          (8)
                                                                                              -------------    -------------  
                                                                                                                                                        
Net  loss                                                                              $            (4,859)  $            (5,911)
                                                                                              =============    =============  
                                                                                                                                                        
                                                                                                                                                        
Loss  per  common  share  -  basic  and  diluted            $              (0.07)  $              (0.22)
                                                                                              -------------    -------------  
                                                                                                                                                        
Weighted  average  shares  -  basic  and  diluted              69,452,487          26,844,583  
                                                                                              =============    =============  
 

1 | 2  Next Page »



Review Article Be the first to review this article



Click here for Internet Business Systems © 2013 Internet Business Systems, Inc.
595 Millich Dr., Suite 210, Campbell, CA 95008
+1 (408) 850-9201 — Contact Us, or visit our other sites:
AECCafe - Architectural Design and EngineeringEDACafe - Electronic Design AutomationGISCafe - Geographical Information Services	MCADCafe - Mechanical Design and EngineeringTechJobsCafe - Technical Jobs and ResumesShareCG  - Share Computer Graphic (CG) Animation, 3D Art and 3D Models
  Privacy Policy